New Studies Prompt FDA to Review AndroGel Safety
By Joe Messa
Philadelphia personal injury lawyers inform patients of the U.S. Food and Drug Administration’s plans to re-examine the safety of AndroGel, a popular testosterone replacement drug prescribed to men. The decision to review the drug comes after two studies demonstrating that men using AndroGel are at a higher risk of heart attacks and strokes were published. […]
Continue reading